Mode
Text Size
Log in / Sign up

Cefdinir and cefprozil show superior eradication rates compared to penicillin V for Group A streptococcal pharyngitisCertain antibiotics work better than others for strep throat

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider cefdinir or cefprozil as effective alternatives to penicillin V; avoid azithromycin due to inferior efficacy.

This network meta-analysis synthesized data from 64 RCTs involving 23,287 participants to evaluate the efficacy of 24 antibiotics for Group A streptococcal (GAS) pharyngitis compared to penicillin V. The analysis focused on early and late bacterial eradication as well as clinical response.

The study found that cefdinir showed greater efficacy for both early bacterial eradication (OR: 3.09; 95% CI: 1.60-6.01) and early clinical response (OR: 2.01; 95% CI: 1.28-3.25) compared to penicillin V. Similarly, cefprozil showed greater efficacy for late bacterial eradication (OR: 3.12; 95% CI: 1.03-11.25). In contrast, azithromycin was associated with inferior eradication rates (early OR: 0.53; 95% CI: 0.32-0.90; late OR: 0.38; 95% CI: 0.25-0.62) and increased adverse events.

A limitation noted by the authors is that evidence for spiramycin's late clinical response was limited to a single small trial. Clinically, while standard penicillins remain preferred first-line therapies, cefdinir serves as an effective alternative. Azithromycin should be avoided due to inferior efficacy and higher risks of adverse events.

How this fits prior evidence

This network meta-analysis addresses the selection of antibiotics for Group A streptococcal pharyngitis. It contrasts with prior evidence regarding azithromycin; while a previous finding noted azithromycin's role in reducing maternal infection, this study indicates azithromycin is associated with inferior eradication rates and increased adverse events in GAS pharyngitis. Furthermore, it provides a comparison of cephalosporins like cefdinir as alternatives to penicillin.

When you have a painful case of strep throat, the right antibiotic makes all the difference in how quickly you feel better and how well the bacteria are cleared from your body. A large review of 64 trials involving over 23,000 people compared 24 different antibiotics to see which ones performed best against Group A streptococcal pharyngitis.

The results show that while penicillin remains a standard first-line treatment, some alternatives perform better in specific ways. For example, cefdinir and cefprozil showed higher rates of clearing the bacteria early and late compared to penicillin V. In contrast, azithromycin performed poorly at clearing the infection and was linked to more side effects.

It is important to note that while these findings help doctors choose the best treatment, some data points are limited. For instance, the evidence for spiramycin's success in later clinical response came from only one small study. Always talk to your doctor to determine which medication is safest and most effective for your specific needs.

What this means for you:
Cefdinir is a strong alternative to penicillin for strep throat, while azithromycin shows lower efficacy and more risks.

Common questions

Is azithromycin effective for strep throat?

The study found that azithromycin had inferior results for clearing bacteria compared to penicillin V. Additionally, patients taking azithromycin experienced a higher number of adverse events. Because of these lower success rates and increased risks, it is generally not the preferred choice for treating this infection.

Is cefdinir a good alternative to penicillin?

Yes, the data shows that cefdinir is an effective alternative. It demonstrated significantly greater efficacy in early clinical response and higher rates of bacterial eradication compared to penicillin V. You should discuss this option with your doctor if you need an alternative.

How do different antibiotics compare for clearing the infection?

While penicillin is a standard treatment, some others performed better in specific areas. Cefdinir and cefproxime proxetil showed greater efficacy in early bacterial eradication than penicillin V. However, azithromycin showed suboptimal performance in both early and late stages of clearing the bacteria.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Penicillin remains the first-line therapy for group A streptococcal (GAS) pharyngitis. However, broad-spectrum antibiotics continue to be widely prescribed in clinical practice. This study aimed to evaluate the relative efficacy and safety profiles of antibiotics for GAS pharyngitis. Literature published through March 2026 was searched. Efficacy outcomes included early and late bacterial eradication, clinical response, and bacteriological recurrence, whereas safety was assessed according to adverse events. Per-protocol data were extracted, and a Bayesian network meta-analysis was performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). We identified 64 RCTs (23,287 participants). For early bacterial eradication, cefdinir (OR: 3.09; 95% CI: 1.60–6.01) and cefpodoxime proxetil (OR: 2.58; 95% CI: 1.07–6.17) demonstrated greater efficacy compared with penicillin V, whereas azithromycin showed inferior eradication rates than penicillin V (OR: 0.53; 95% CI: 0.32–0.90). For late bacterial eradication, cefprozil demonstrated greater efficacy compared with penicillin V (OR: 3.12; 95% CI: 1.03–11.25), whereas azithromycin exhibited suboptimal performance (OR: 0.38; 95% CI: 0.25–0.62). For early clinical response, cefdinir (OR: 2.01; 95% CI: 1.28–3.25) and cefuroxime axetil (OR: 2.14; 95% CI: 1.19–3.60) demonstrated significantly greater efficacy compared with penicillin V. For late clinical response, spiramycin showed superior efficacy to penicillin V (OR: 0.17; 95% CI: 0.02–0.94), although evidence was limited to a single small trial. Azithromycin was associated with reduced efficacy, higher late recurrence rates, and increased adverse events. Standard penicillins should remain the preferred first-line therapy for GAS pharyngitis to support antimicrobial stewardship. Cefdinir represents an effective alternative. Conversely, azithromycin should be avoided due to inferior efficacy and increased adverse risks. http://www.crd.york.ac.uk/prospero, identifier CRD420251104703.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.